Tonix Pharmaceuticals (NASDAQ:TNXP) just reported results for the second quarter of 2024.
- Tonix Pharmaceuticals reported earnings per share of -$19.28. This was below the analyst estimate for EPS of -$7.20.
- The company reported revenue of $2.21 million.
- This was 34.09% worse than the analyst estimate for revenue of $3.35 million.